Research study Program year 2022 Source: CMS Open Payments

Phase 2, Multi-Arm Study of Niraparib Administered Alone and in Combin

Research payments

$966,050

144 payments

Through program year 2022, $966,050 in research payments was reported against Phase 2, Multi-Arm Study of Niraparib Administered Alone and in Combin, across 144 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$313,924	36
2021	Research	$189,428	45
2020	Research	$462,697	63

Breakdown

Who paid Research payments · program years 2020–2022

GlaxoSmithKline, LLC. $966,050 144 payments

Who received the money Research payments · program years 2020–2022

Innovative Clinical Research Institute LLC Organisation paid for research $312,267 37 payments
Northwest Medical Specialties Pllc Organisation paid for research $141,570 6 payments
Sarah Cannon Research Institute LLC Organisation paid for research $124,819 16 payments
Sarah Cannon Research Institute LLC 1 Organisation paid for research $50,689 15 payments
Hematology Oncology Associates Of The Treasure Coast Organisation paid for research $45,910 9 payments
Uh Cleveland Medical Center Teaching hospital · OH $45,172 3 payments
Emory University Organisation paid for research $42,170 6 payments
Ingalls Memorial Hospital Organisation paid for research $34,932 10 payments
Kadlec Regional Medical Center Organisation paid for research $29,761 6 payments
Healthcare Research Network Organisation paid for research $23,762 7 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.